Cervical Cancer - Pipeline Review, H2 2017

  • ID: 4433861
  • Report
  • 674 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Abion Inc
  • AVEO Pharmaceuticals Inc
  • Eisai Co Ltd
  • Glycotope GmbH
  • MedImmune LLC
  • Pharma Mar SA
  • MORE
Cervical Cancer - Pipeline Review, H2 2017

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Pipeline Review, H2 2017, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.

Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia is characterized by abnormal appearance of cells on the surface of the cervix. Cervical dysplasia usually occurs in women aging twenty five to thirty five. Most cases of cervical dysplasia are caused by human papilloma virus (HPV). Factors contributing to cervical dysplasia include using immunosuppressants and smoking. Signs and symptoms include genital warts, abnormal bleeding, spotting after intercourse, vaginal discharge and low back pain.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Cervical Cancer - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Cervical Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cervical Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cervical Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 6, 34, 36, 47, 9 and 4 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 4, 4, 11 and 6 molecules, respectively.

Cervical Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Cervical Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Cervical Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Cervical Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Cervical Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Cervical Cancer (Oncology)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Cervical Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Cervical Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abion Inc
  • AVEO Pharmaceuticals Inc
  • Eisai Co Ltd
  • Glycotope GmbH
  • MedImmune LLC
  • Pharma Mar SA
  • MORE
Introduction

Cervical Cancer - Overview

Cervical Cancer - Therapeutics Development

Cervical Cancer - Therapeutics Assessment

Cervical Cancer - Companies Involved in Therapeutics Development

Cervical Cancer - Drug Profiles

Cervical Cancer - Dormant Projects

Cervical Cancer - Discontinued Products

Cervical Cancer - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Cervical Cancer, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017

Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Products under Development by Companies, H2 2017 (Contd..6), H2 2017

Products under Development by Companies, H2 2017 (Contd..7), H2 2017

Products under Development by Universities/Institutes, H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Cervical Cancer - Pipeline by Abion Inc, H2 2017

Cervical Cancer - Pipeline by Abivax SA, H2 2017

Cervical Cancer - Pipeline by Admedus Ltd, H2 2017

Cervical Cancer - Pipeline by Advaxis Inc, H2 2017

Cervical Cancer - Pipeline by Advenchen Laboratories LLC, H2 2017

Cervical Cancer - Pipeline by Agenus Inc, H2 2017

Cervical Cancer - Pipeline by Amgen Inc, H2 2017

Cervical Cancer - Pipeline by AntiCancer Inc, H2 2017

Cervical Cancer - Pipeline by Antigen Express Inc, H2 2017

Cervical Cancer - Pipeline by Arbor Vita Corp, H2 2017

Cervical Cancer - Pipeline by ArQule Inc, H2 2017

Cervical Cancer - Pipeline by Asana BioSciences LLC, H2 2017

Cervical Cancer - Pipeline by AstraZeneca Plc, H2 2017

Cervical Cancer - Pipeline by AVEO Pharmaceuticals Inc, H2 2017

Cervical Cancer - Pipeline by Bayer AG, H2 2017

Cervical Cancer - Pipeline by BeiGene Ltd, H2 2017

Cervical Cancer - Pipeline by Bioleaders Corp, H2 2017

Cervical Cancer - Pipeline by Biomics Biotechnologies Co Ltd, H2 2017

Cervical Cancer - Pipeline by Blirt SA, H2 2017

Cervical Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2017

Cervical Cancer - Pipeline by Bristol-Myers Squibb Co, H2 2017

Cervical Cancer - Pipeline by Cadila Healthcare Ltd, H2 2017

Cervical Cancer - Pipeline by Cancer Research Technology Ltd, H2 2017

Cervical Cancer - Pipeline by Celleron Therapeutics Ltd, H2 2017

Cervical Cancer - Pipeline by Coherus BioSciences Inc, H2 2017

Cervical Cancer - Pipeline by Critical Outcome Technologies Inc, H2 2017

Cervical Cancer - Pipeline by Cytori Therapeutics Inc, H2 2017

Cervical Cancer - Pipeline by CZ BioMed Corp, H2 2017

Cervical Cancer - Pipeline by DelMar Pharmaceuticals Inc, H2 2017

Cervical Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2017

Cervical Cancer - Pipeline by Eisai Co Ltd, H2 2017

Cervical Cancer - Pipeline by Etubics Corp, H2 2017

Cervical Cancer - Pipeline by Eureka Therapeutics Inc, H2 2017

Cervical Cancer - Pipeline by EyeGene Inc, H2 2017

Cervical Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2 2017

Cervical Cancer - Pipeline by Formune SL, H2 2017

Cervical Cancer - Pipeline by GamaMabs Pharma SA, H2 2017

Cervical Cancer - Pipeline by Gene Techno Science Co Ltd, H2 2017

Cervical Cancer - Pipeline by Genentech Inc, H2 2017

Cervical Cancer - Pipeline by Genmab A/S, H2 2017

Cervical Cancer - Pipeline by Genor BioPharma Co Ltd, H2 2017

Cervical Cancer - Pipeline by GlaxoSmithKline Plc, H2 2017

Cervical Cancer - Pipeline by Glycostem Therapeutics BV, H2 2017

Cervical Cancer - Pipeline by Glycotope GmbH, H2 2017

Cervical Cancer - Pipeline by Gradalis Inc, H2 2017

Cervical Cancer - Pipeline by Immunomedics Inc, H2 2017

Cervical Cancer - Pipeline by Immunovaccine Inc, H2 2017

Cervical Cancer - Pipeline by Innate Pharma SA, H2 2017

Cervical Cancer - Pipeline by Innovation Pharmaceuticals Inc, H2 2017

Cervical Cancer - Pipeline by Iovance Biotherapeutics Inc, H2 2017

Cervical Cancer - Pipeline by ISA Pharmaceuticals BV, H2 2017

Cervical Cancer - Pipeline by Johnson & Johnson, H2 2017

Cervical Cancer - Pipeline by Juno Therapeutics Inc, H2 2017

Cervical Cancer - Pipeline by Kaketsuken, H2 2017

Cervical Cancer - Pipeline by Karyopharm Therapeutics Inc, H2 2017

Cervical Cancer - Pipeline by Kite Pharma Inc, H2 2017

Cervical Cancer - Pipeline by LondonPharma Ltd, H2 2017

Cervical Cancer - Pipeline by Mabion SA, H2 2017

Cervical Cancer - Pipeline by MedImmune LLC, H2 2017

Cervical Cancer - Pipeline by Merck & Co Inc, H2 2017

Cervical Cancer - Pipeline by Merck KGaA, H2 2017

Cervical Cancer - Pipeline by Mycenax Biotech Inc, H2 2017

Cervical Cancer - Pipeline by Nektar Therapeutics, H2 2017

Cervical Cancer - Pipeline by NeoImmuneTech Inc, H2 2017

Cervical Cancer - Pipeline by Ology Bioservices Inc, H2 2017

Cervical Cancer - Pipeline by Oncobiologics Inc, H2 2017

Cervical Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H2 2017

Cervical Cancer - Pipeline by Oryx GmbH & Co KG, H2 2017

Cervical Cancer - Pipeline by PDS Biotechnology Corp, H2 2017

Cervical Cancer - Pipeline by Pfizer Inc, H2 2017

Cervical Cancer - Pipeline by Pharma Mar SA, H2 2017

Cervical Cancer - Pipeline by Psicofarma SA de CV, H2 2017

Cervical Cancer - Pipeline by Puma Biotechnology Inc, H2 2017

Cervical Cancer - Pipeline by Regeneron Pharmaceuticals Inc, H2 2017

Cervical Cancer - Pipeline by Rexahn Pharmaceuticals Inc, H2 2017

Cervical Cancer - Pipeline by Richter Gedeon Nyrt, H2 2017

Cervical Cancer - Pipeline by Samyang Holdings Corp, H2 2017

Cervical Cancer - Pipeline by Sanofi, H2 2017

Cervical Cancer - Pipeline by Seattle Genetics Inc, H2 2017

Cervical Cancer - Pipeline by Selecta Biosciences Inc, H2 2017

Cervical Cancer - Pipeline by Shantha Biotechnics Pvt Ltd, H2 2017

Cervical Cancer - Pipeline by Sirnaomics Inc, H2 2017

Cervical Cancer - Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2017

Cervical Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2 2017

Cervical Cancer - Pipeline by Theralase Technologies Inc, H2 2017

Cervical Cancer - Pipeline by Theravectys SA, H2 2017

Cervical Cancer - Pipeline by THEVAX Genetics Vaccine USA Inc, H2 2017

Cervical Cancer - Pipeline by UbiVac LLC, H2 2017

Cervical Cancer - Pipeline by Vectorite Biomedica Inc, H2 2017

Cervical Cancer - Pipeline by VLPbio, H2 2017

Cervical Cancer - Pipeline by Wellstat Biologics Corp, H2 2017

Cervical Cancer - Pipeline by Zeria Pharmaceutical Co Ltd, H2 2017

Cervical Cancer - Dormant Projects, H2 2017

Cervical Cancer - Dormant Projects, H2 2017 (Contd..1), H2 2017

Cervical Cancer - Dormant Projects, H2 2017 (Contd..2), H2 2017

Cervical Cancer - Dormant Projects, H2 2017 (Contd..3), H2 2017

Cervical Cancer - Dormant Projects, H2 2017 (Contd..4), H2 2017

Cervical Cancer - Discontinued Products, H2 2017

List of Figures

Number of Products under Development for Cervical Cancer, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Routes of Administration, H2 2017

Number of Products by Stage and Routes of Administration, H2 2017

Number of Products by Top 10 Molecule Types, H2 2017

Number of Products by Stage and Top 10 Molecule Types, H2
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abion Inc
  • Abivax SA
  • Admedus Ltd
  • Advaxis Inc
  • Advenchen Laboratories LLC
  • Agenus Inc
  • Amgen Inc
  • AntiCancer Inc
  • Antigen Express Inc
  • Arbor Vita Corp
  • ArQule Inc
  • Asana BioSciences LLC
  • AstraZeneca Plc
  • AVEO Pharmaceuticals Inc
  • Bayer AG
  • BeiGene Ltd
  • Bioleaders Corp
  • Biomics Biotechnologies Co Ltd
  • Blirt SA
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co
  • Cadila Healthcare Ltd
  • Cancer Research Technology Ltd
  • Celleron Therapeutics Ltd
  • Coherus BioSciences Inc
  • Critical Outcome Technologies Inc
  • Cytori Therapeutics Inc
  • CZ BioMed Corp
  • DelMar Pharmaceuticals Inc
  • Dr. Reddy's Laboratories Ltd
  • Eisai Co Ltd
  • Etubics Corp
  • Eureka Therapeutics Inc
  • EyeGene Inc
  • F. Hoffmann-La Roche Ltd
  • Formune SL
  • GamaMabs Pharma SA
  • Gene Techno Science Co Ltd
  • Genentech Inc
  • Genmab A/S
  • Genor BioPharma Co Ltd
  • GlaxoSmithKline Plc
  • Glycostem Therapeutics BV
  • Glycotope GmbH
  • Gradalis Inc
  • Immunomedics Inc
  • Immunovaccine Inc
  • Innate Pharma SA
  • Innovation Pharmaceuticals Inc
  • Iovance Biotherapeutics Inc
  • ISA Pharmaceuticals BV
  • Johnson & Johnson
  • Juno Therapeutics Inc
  • Kaketsuken
  • Karyopharm Therapeutics Inc
  • Kite Pharma Inc
  • LondonPharma Ltd
  • Mabion SA
  • MedImmune LLC
  • Merck & Co Inc
  • Merck KGaA
  • Mycenax Biotech Inc
  • Nektar Therapeutics
  • NeoImmuneTech Inc
  • Ology Bioservices Inc
  • Oncobiologics Inc
  • Ono Pharmaceutical Co Ltd
  • Oryx GmbH & Co KG
  • PDS Biotechnology Corp
  • Pfizer Inc
  • Pharma Mar SA
  • Psicofarma SA de CV
  • Puma Biotechnology Inc
  • Regeneron Pharmaceuticals Inc
  • Rexahn Pharmaceuticals Inc
  • Richter Gedeon Nyrt
  • Samyang Holdings Corp
  • Sanofi
  • Seattle Genetics Inc
  • Selecta Biosciences Inc
  • Shantha Biotechnics Pvt Ltd
  • Sirnaomics Inc
  • Sun Pharma Advanced Research Company Ltd
  • Tessa Therapeutics Pte Ltd
  • Theralase Technologies Inc
  • Theravectys SA
  • THEVAX Genetics Vaccine USA Inc
  • UbiVac LLC
  • Vectorite Biomedica Inc
  • VLPbio
  • Wellstat Biologics Corp
  • Zeria Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll